Histone acetyltransferase p300 regulates the expression of human pituitary tumor transforming gene (hPTTG)

Tian Li; Hui Huang; Binlu Huang; Baiqu Huang; Jun Lu

doi:10.1016/S1673-8527(08)60122-8

Volume 36 Issue 6

Jun. 2009

Turn off MathJax

Article Contents

Article Navigation > Journal of Genetics and Genomics > 2009 > 36(6): 335-342

PDF( 328 KB)

Histone acetyltransferase p300 regulates the expression of human pituitary tumor transforming gene (hPTTG)

doi: 10.1016/S1673-8527(08)60122-8

a
Key Laboratory of Molecular Epigenetics of Ministry of Education, Institute of Genetics and Cytology, Northeast Normal University, Changchun 130024, China
b
Changchun University of Science and Technology, Changchun 130022, China

More Information

Corresponding author: E-mail address: luj809@nenu.edu.cn (Jun Lu)
Received Date: 2008-12-15
Accepted Date: 2009-03-09
Rev Recd Date: 2009-02-22

Available Online: 2009-06-16

Publish Date: 2009-06-20

Abstract

Abstract

The human pituitary tumor transforming gene (hPTTG) serves as a marker for malignancy grading in several cancers. hPTTG is involved in multiple cellular pathways including cell transformation, apoptosis, DNA repair, genomic instability, mitotic control and angiogenesis induction. However, the molecular mechanisms underlying hPTTG regulation have not been fully explored. In this study, we found that overexpression of histone acetyltransferase (HAT) p300 upregulated hPTTG at the levels of promoter activity, mRNA and protein expression. Moreover, the HAT activity of p300 was critical for its regulatory function. Chromatin immunoprecipitation (ChIP) analysis revealed that overexpression of p300 elevated the level of histone H3 acetylation on the hPTTG promoter. Additionally, the NF-Y sites at the hPTTG promoter exhibited a synergistic effect on upregulation of hPTTG through interacting with p300. We also found that treatment of 293T cells with the histone deacetylase (HDAC) inhibitor Trichostatin A (TSA) increased hPTTG promoter activity. Meanwhile, we provided evidence that HDAC3 decreased hPTTG promoter activity. These data implicate an important role of the histone acetylation modification in the regulation of hPTTG.
- histone acetylation,
- p300,
- NF-Y,
- transcription regulation

FullText(HTML)

References(25)

References

[1]	Boelaert, K., Tannahill, L.A., Bulmer, J.N. et al. Faseb. J., 17 (2003),pp. 1631-1639
[2]	Chan, H.M., La Thangue, N.B. p300/CBP proteins: HATs for transcriptional bridges and scaffolds J. Cell Sci., 114 (2001),pp. 2363-2373
[3]	Chen, L., Puri, R., Lefkowitz, E.J. et al. Gene, 248 (2000),pp. 41-50
[4]	Clem, A.L., Hamid, T., Kakar, S.S. Gene, 322 (2003),pp. 113-121
[5]	Currie, R.A. NF-Y is associated with the histone acetyltransferases GCN5 and P/CAF J. Biol. Chem., 273 (1998),pp. 1430-1434
[6]	Deng, Q., Li, Y., Tedesco, D. et al. The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins Cancer Res., 65 (2005),pp. 8298-8307
[7]	Faisst, S., Meyer, S. Compilation of vertebrate-encoded transcription factors Nucleic Acids Res., 20 (1992),pp. 3-26
[8]	Faniello, M.C., Bevilacqua, M.A., Condorelli, G. et al. The B subunit of the CAAT-binding factor NFY binds the central segment of the co-activator p300 J. Biol. Chem., 274 (1999),pp. 7623-7626
[9]	Imagawa, M., Chiu, R., Karin, M. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: Protein kinase C and cAMP Cell, 51 (1987),pp. 251-260
[10]	Kakar, S.S. Cytogenet. Cell Genet., 83 (1998),pp. 93-95
[11]	Kakar, S.S. Gene, 240 (1999),pp. 317-324
[12]	Kakar, S.S., Jennes, L. Cytogenet. Cell Genet., 84 (1999),pp. 211-216
[13]	Kim, D.S., Fong, J., Read, M.L. et al. Mol. Cell Endocrinol., 278 (2007),pp. 1-6
[14]	Li, Q., Herrler, M., Landsberger, N. et al. EMBO J., 17 (1998),pp. 6300-6315
[15]	Livak, K.J., Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods, 25 (2001),pp. 402-408
[16]	Mantovani, R. The molecular biology of the CCAAT-binding factor NF-Y Gene, 239 (1999),pp. 15-27
[17]	Pei, L., Melmed, S. Mol. Endocrinol., 11 (1997),pp. 433-441
[18]	Prezant, T.R., Kadioglu, P., Melmed, S. J. Clin. Endocrinol. Metab., 84 (1999),pp. 1149-1152
[19]	Salsi, V., Caretti, G., Wasner, M. et al. Interactions between p300 and multiple NF-Y trimers govern cyclin B2 promoter function J. Biol. Chem., 278 (2003),pp. 6642-6650
[20]	Suzuki, K., Nagasawa, H., Uto, Y. et al. Bioorg. Med. Chem., 13 (2005),pp. 4014-4021
[21]	Uramoto, H., Wetterskog, D., Hackzell, A. et al. p73 competes with co-activators and recruits histone deacetylase to NF-Y in the repression of PDGF beta-receptor J. Cell Sci., 117 (2004),pp. 5323-5331
[22]	Van Lint, C., Emiliani, S., Verdin, E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation Gene Expr., 5 (1996),pp. 245-253
[23]	Wang, X., Feng, Y., Pan, L. et al. The proximal GC-rich region of p16(INK4a) gene promoter plays a role in its transcriptional regulation Mol. Cell Biochem., 301 (2007),pp. 259-266
[24]	Xin, J.H., Cowie, A., Lachance, P. et al. Genes Dev., 6 (1992),pp. 481-496
[25]	Zhang, X., Horwitz, G.A., Prezant, T.R. et al. Mol. Endocrinol., 13 (1999),pp. 156-166